Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 29Active not recruiting 26Completed 5Withdrawn 4Not yet recruiting 4Terminated 1Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Lymphoid 5Genitourinary 5Gastrointestinal 4Sarcoma 3Myeloid 3CNS 3Breast 3Tumor-Agnostic 2Dermatologic 2Thoracic 1Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Ovarian Neoplasms 1Neoplasm Metastasis 1

Interventions

Nivolumab 3Interviews as Topic 2tivozanib 1taxane 1palbociclib 1gedatolisib 1atezolizumab 1aldesleukin 1X-Rays 1Specimen Handling 1Quality of Life 1Phantoms, Imaging 1Pemetrexed 1Paclitaxel 1Nutritional Status 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Infusions, Parenteral 1Hyperthermic Intraperitoneal Chemotherapy 1E-3810 1Doxorubicin 1Cisplatin 1CTLA-4 Antigen 1Blood Transfusion 1Blood Specimen Collection 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Specimen Handling × Gynecologic × Clear all
NCT04840589 2026-05-13

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

National Cancer Institute (NCI)

Phase 1 Suspended
66 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡